| |
Alternative
Photosensitization Assay in the Mouse (Photo-LLNA)
This proposal, Alternative Photosensitization
Assay in the Mouse (Photo-LLNA), is an alternative animal test designed to identify
substances with immunotoxic properties. There has evolved clear public opinion, as
well as an industry demand and a governmental mandate to develop alternative toxicity
tests that refine, reduce, or replace the use of animal models. Due to increasing concerns over the photoallergic
(photosensitizing) properties of chemicals, there is an increasing need for rapid,
cost-effective assays, which can predict not only sensitization, but also
photosensitization. The Local Lymph Node Assay has proven to be a useful, sensitive
model for detecting sensitizers. The purpose
of this proposal is to demonstrate the feasibility of employing the LLNA, with flow
cytometry endpoints, combined with UV irradiation, as a test system to identify potential
photosensitizers or photoirritants. Few
papers have been published in the literature using this model, thus this is a relatively
novel application of this test system. The choice of a mouse model has several
advantages including the use of an existing, known predictive mechanistic assay system,
which is rapid, cost-effective, and minimizes pain and distress to animals. The Photo-LLNA Assay will provide a sensitive test
system while (1) complying with the Animal Welfare Act by directly addressing the 3Rs; (2)
increasing the discriminating power and quality of data generated when compared to
existing methods; and (3) greatly reducing the costs associated with the use of animals
for photosensitization studies.
Keywords: Photosensitization,
photoallergy, ultraviolet light, immunotoxicity, flow cytometry, animal alternative, lymph
node
Commercial Applications: MB
Research will offer the service of an alternative photosensitization assay to members of
the pharmaceutical, biotech, cosmetic, and chemical industry. A survey of our clients indicates there is an
increasing demand for rapid and cost-effective photosensitization tests, as well as for
mechanistic-based tests, which provide both qualitative and quantitative information. In addition, we believe that flow cytometry is
underutilized in the toxicity-screening field and that this technology can be used to
develop other commercially viable in vivo and in vitro toxicity tests at our
company.
For more information about this assay, please click
here.
|
|